However, Kan et al. (Kan et al., 2024) indicated that Nerve Growth Factor enhances analgesia in an experimental mouse model of cancer pain by up-regulating membrane-associated opioid receptors, suggesting that the Nerve Growth Factor-TrkA signalling pathway also plays an upstream regulatory role in the mechanism of analgesia. The gene discussed is NGF; the disease is cancer.